UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Takeda Korea labor union to ask Japanese headquarters about restructuring
by Kim Yun-mi
2019-09-19 14:11
Chong Kun Dang releases trial result for diabetes treatment
by Lee Han-soo
2019-09-19 14:11
Indian biosimilar of rituximab to undergo test in Korea
by Lee Hye-seon
2019-09-19 10:31
Ono Pharma, BMS unveil two P3 trial analyses for Opdivo
by Lee Han-soo
2019-09-18 15:48
CJ Healthcare to export gastroesophageal reflux treatment to Indonesia
by Lee Han-soo
2019-09-18 11:37
라인
Will Tagrisso study results affect use of EGFR TKIs in lung cancer?
by Kim Yun-mi
2019-09-18 11:36
Hanmi spurs new immunotherapy development through open innovation
by Lee Han-soo
2019-09-17 18:14
‘Lundbeck to work with parliament to prevent suicide in Korea’
by Kim Yun-mi
2019-09-17 15:19
Shinpoong's malaria treatment expands global presence
by Lee Han-soo
2019-09-17 15:13
SK Bioscience to export influenza vaccine to Asian countries
by Lee Han-soo
2019-09-17 11:27
라인
Lenvima to get benefit as 1st-line treatment of hepatocellular carcinoma
by Kim Yun-mi
2019-09-16 16:20
'Roche Korea to put patient accessibility first'
by Lee Han-soo
2019-09-16 15:41
GC’s Hunter syndrome drug to get priority screening in China
by Lee Han-soo
2019-09-16 13:56
GSK’s chronic hand eczema treatment faces local competition
by Lee Han-soo
2019-09-12 07:22
Chong Kun Dang wins patent suit against Novartis over immunosuppressant
by Jeong Sae-im
2019-09-11 15:16
라인
AstraZeneca to challenge Roche in small-cell lung cancer treatment market
by Kim Yun-mi
2019-09-11 14:18
Amgen fetes 1st anniversary of getting expanded indication for Repatha
by Lee Han-soo
2019-09-11 13:56
Hanmi to launch 3-substance combination in Latin America
by Lee Han-soo
2019-09-11 13:56
Daewoong to test botulinum toxin Nabota for hair loss
by Jeong Sae-im
2019-09-11 13:56
Novartis withdraws suit against Ahngook’s generic drug
by Jeong Sae-im
2019-09-10 15:38
-
이전
31
32
33
34
35
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top